Veradermics, Inc
Pharmaceutical company · New Haven, Connecticut, United States · NYSE: MANE
Veradermics, Inc is a pharmaceutical company headquartered in New Haven, Connecticut, United States. Its earliest recorded incorporation is in 2021. Its shares trade on NYSE under the ticker MANE. It has reported private securities offerings to the US SEC, most recently $30 million sold in a notice filed in 2026.
Veradermics at a glance
What does Veradermics do?
Private fundraising reported to the SEC
7 Form D notices; the most recent reported $30 million sold (2026).
Frequently asked questions about Veradermics
Where is Veradermics headquartered?
Veradermics, Inc is headquartered in New Haven, Connecticut, United States.
What does Veradermics do?
Veradermics, Inc is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Veradermics a public company?
Yes. Veradermics, Inc trades on NYSE under the ticker MANE.
When was Veradermics founded?
The earliest incorporation on record for Veradermics, Inc is in 2021, according to public company registers.
Similar companies
- Arvinas, Inc.New Haven, Connecticut, United States
- Yarrow Bioscience, Inc.New Haven, Connecticut, United States
- Trevi Therapeutics, Inc.New Haven, Connecticut, United States
- Rallybio CorpNew Haven, Connecticut, United States
- Achillion Pharmaceuticals IncNew Haven, Connecticut, United States
- Biohaven Ltd.New Haven, Connecticut, United States
- BioXcel Therapeutics, Inc.New Haven, Connecticut, United States
- Biohaven Pharmaceutical Holding Co Ltd.New Haven, Connecticut, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-24. Data licences